Key result
Major bleeding in AF patients on OAC is linked to increased future CV event risk.
Why the study?
Does major bleeding increase the risk of future cardiovascular events in patients with atrial fibrillation on oral anticoagulation?
Does major bleeding increase the risk of future cardiovascular events in patients with atrial fibrillation on oral anticoagulation?
Answers are grounded in this paper and cite their sources.
Major bleeding is highlighted as a significant problem associated with future cardiovascular events in AF patients on oral anticoagulation.
Bleeding and risk of subsequent events for patients with AF on anticoagulation. AF, atrial fibrillation; aHR, adjusted hazard ratio; LAA, left atrial appendage; MI, myocardial infarction; NSAID, non-steroidal anti-inflammatory drugs.
No takes yet. Share an insight, caveat, or question.
Harrington et al. (2022) studied this question. Major bleeding in patients with atrial fibrillation on oral anticoagulation is associated with an increased risk of future cardiovascular events.
Synapse has enriched 10 related papers. Consider them for comparative context: